Docket Number:13A-1000222
Inventor:Yu-Chan Chao, Yueh-Lung Wu, Carol PeiYin Wu, Chia-Hung Wang
IP Status:US 8598136、I 460271
Abstract:
In order to enhance transgene expression of baculoviral vector in mammalian cells, we use RNAi silencing to suppress cellular antiviral mechanisms. This invention relates to a method for expressing a gene in a mammalian cell. The method includes introducing into a cell an agent that inhibits one or both of miRNA pathway and antiviral defense pathway; and a baculovirus that contains a nucleic acid molecule including a gene operably linked to a promoter; and expressing the gene in the cell.
Fields of Application:
- Improve the yield of vaccine
- High quality protein expression
- Foreign gene expression for gene therapy
- Improve the efficiency of iPSCs transformation
Advantages when compared to the existing technologies:
Advantage of Baculovirus expression system:
- Biosafety: Due to the non-replication and non-integration natures in mammalian cells, baculoviral vector is much safer than other viral vector systems.
- High packaging capacity: >38Kb, much better than other viral vectors (<10Kb).
- Low cytotoxicity: High survival rate of transduced cells.
- Ease of manipulation: Easy to construction, safe and time-saving. Many commercial kits are available.
Contact Person:Sue-Ming Chang / 886-2-2787-2600 / name4517@gate.sinica.edu.tw
